Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Altana reports decisive progress in development of roflumilast and ciclesonide

Aug. 29, 2001

Demegen receives grant in support of P-113D development for cystic fibrosis infections

Aug. 28, 2001

Potent inhibitors of IL-5 gene expression identified at Abbott

Aug. 27, 2001

Genaera initiates first clinical trial for Lomucin

Aug. 24, 2001

Grelan designs new series of PDE4 inhibitors

Aug. 23, 2001

FDA approves combination antihistamine/decongestant Zyrtec-D

Aug. 23, 2001

New orally active elastase inhibitors reported by Sanofi-Synthelabo

Aug. 21, 2001

Icos patents new potent and selective PDE4 inhibitors

Aug. 20, 2001

Flavonoid consumption associated with reduced incidence of COPD

Aug. 20, 2001

Phase I trial initiated for Inspire's sinusitis therapy

Aug. 20, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...